The Systems Biology Markup Language (SBML) is the leading modelling language within systems biology. It is a computer-readable format for representing models of biochemical reaction networks in software. SBML has been evolving since 2000 thanks to an international community of software developers and users. At the same time the Modelica language has evolved as the leading object-oriented modelling language for convenient, componentoriented modelling of complex physical systems. 
The BioChem Library
The first beta version of the BioChem library was developed by Larsdotter Nilsson at the Linköping University [1] . The design idea behind the BioChem library is to create a general purpose Modelica library for modelling, simulation and visualization of biological and biochemical systems. The models implemented in the BioChem library describe substances and reactions that can take place in-between these substances in a diverse number of biochemical pathways. An example pathway is shown in Figure 1 .
Figure 1 Simple pathway model using components from the BioChem library.
Version 1.0 of the library has now been completed and is publicly available [2] .
Modelica to SBML Translator
A translator that converts Modelica to SBML [3] , and vice versa, has been developed. The translator is able to convert SBML models that are compliant with SBML Level 2, version 3. The Modelica models created are Modelica 2.2 and 3 compliant. Modelica models are translated to SBML Level 2, version 1, 2 or 3.
SBML
SBML is based on XML, making it more suitable to read and write by computers than by humans. SBML is a model representation format for systems biology, created with an objective to become a common intermediate format for software tools. The idea is that a large support for SBML enables the use of a wide range of different tools without having to rewrite models. In principle, a SBML model consists of a number of components, describing biochemical enti-ties (species) and transformations (reactions and rules) forming a biochemical network. In addition it is also possible to describe instantaneous discontinuous state changes using events, and operating assumptions for the model using constraints.
Design principles
Whereas SBML is a very specific language for describing models within the systems biology field only, Modelica is a much more general and expressive language. One of the challenges in writing a translator lies in finding a way to map different language constructs and features between the two languages. There is no obvious one-to-one mapping as there are usually many different ways of describing things in Modelica. One way to solve this is to try and catch all possible constructs in Modelica and map them to SBML. Another way is to restrict how Modelica models may be constructed in order to reduce the number of possibilities. In MathModelica a combination is used. The BioChem library provides the user with the building blocks that must be used in order for a model to be exportable to SBML. MathModelica also provides wizards to help the user build custom components, such as reactions and compartments. These wizards are interactive step-by-step guides, serving two purposes, guiding the user through complex operations and helping the user create models that will be exportable to SBML.
Verification of the translator
The translator has been tested by importing all curated models from the BioModels database [4] release 14. Table 1 shows the percentage of models that (a) are possible to import to MathModelica without failure, (b) give the same simulation result as the reference simulation, and (c) give the same simulation result after exporting to SBML. 
Comparison with other tools
The models in the BioModels database have been developed in different SBML tools, such as Systems Biology Workbench (SBW) [5] , CellDesigner [6] , and Copasi [7] . The results indicate that MathModelica has a good support for the SBML language, especially in comparison with SBW and CellDesigner, however improvements are still needed to reach a complete support.
Related work
The BioDyn [8] [9] [10] software can make external calls to a few other software, including OpenModelica [11] [12] . It also includes import functionality from Modelica to SBML. However, SBML models are imported as flat Modelica i.e. the pathway diagram is lost in the translation. There is also some other related work done, but with limited or no public information available.
Modelling Example
The Dalla Man model [4] is one of the best available models for the whole-body glucose-insulin system, and the model has even been formally accepted as a viable tool when certifying new drugs for diabetes. This model is, however, a non object-oriented model developed in MATLAB. Based on this model a multi-level object-oriented whole-body model of the glucose-insulin system has been developed using MathModelica, MATLAB, and -for the communication between them -SBML.
Creating an object-oriented model
The original MATLAB model was exported to SBML and inserted in MathModelica, and then reformulated into an object-oriented format, in which each object typically correspond to an organ, thus making it possible to successively replace respective organ with more detailed models. The top level of the model can be seen in Figure 2 . As long as the input-output profiles of the replaced organ is preserved this can be done with negligible effects on the whole-body level.
Detailed adipose tissue model
A detailed model for the adipose tissue (fat tissue) was developed (in MATLAB) using mechanistic a priori information and existing and novel data from experiments on human fat cells. The parameters of the model were then optimized so that the simulations fitted both the input-output profile of the old model, and the cell-level data. The model was exported to SBML, and then imported to MathModelica, and inserted in the wholebody model. As expected, this new detailed module did not cause any major changes in the whole-body behaviour (Figure 3) , even though the intercellular glucose utilization rate (i.e. within the altered adipose tissue) had a somewhat different profile ( Figure  4) . Hence, the resulting object-oriented model can be said to have a "zoomable" adipose tissue.
To further show the strength of the object-oriented model, a parameter in the insulin signalling cascade was changed, so that the adipose tissue became 5 times less sensitive to insulin. This corresponds to a diabetic fat tissue in an otherwise healthy body. The simulations (Figure 2 and 3 ) predict that these rather big intracellular changes only leads to slightly higher glucose in the plasma, since a healthy body easily can adapt to the new situation, by slightly increasing the insulin level.
A main strength of the developed model is that it has the ability to translate mechanistically oriented simulations on the biochemical/cellular level, which is the level were drugs act, to the whole-body level, which is the level of clinical interest. Another important benefit of object-oriented modelling is that the modeller is forced to adopt the cell- oriented experiments to physiologically realistic conditions, compatible with the whole-body dynamics.
Figure 3 Simulation results of glucose concentration in plasma of the original model (-), with the mechanistic fat tissue module included (---), and with changed parameters on fat tissue module-level (···).

Figure 4 Simulation results of glucose utilization rate by adipose tissue of the original model (-), with the mechanistic fat tissue module included (---), and with changed parameters on fat tissue module-level (···).
Publishing on the Web
In order to communicate results with others a publish feature has been developed for MathModelica. Once a Modelica model has been developed it can be exported to an interactive HTML page. It is possible to publish not only the selected model, but also its components. The exported model contains interactive model diagram based on the Silverlight technology [14] ), model information (documentation), and selected results. Figure 5 shows an example of a published central metabolism model, originally developed by Selivanov et al [3] .
Publishing on the BioBridge portal
Models can also be published as an integrated part of the BioBridge portal. The BioBridge portal allows modellers (and other users) to access an integrated resource including clinical, genomic, proteomic, and metabolomic information for the metabolic pathways affected by disorders such as chronic obstructive pulmonary disease (COPD), cardiac disease and diabetes. This information is then applied to model the underlying metabolic network. This, in turn, can then be utilized by the modeller for simultaneous analysis of multilevel data in order to improve existing knowledge on complex disorders. 
Connecting to BioXM
The MathModelica Systems Biology toolbox also includes the possibility to tag substances in order to associate a specific substance with information available in the knowledge management environment BioXM [17] [18] . When a user selects a substance with a tag, an http request is made to the BioBridge portal and information is retrieved using BioXM, as illustrated in Figure 6 . BioXM directly, or by access to their WebService query interfaces, integrates more than 20 different public databases and ontologies (see Table 3 for integrated databases) representing a total of 80 793 genes (30 246 human, 27 237 mouse, 23 310 rat), 1 307 pathways, 78 528 compounds, 1 525 474 protein interactions a total of 3 666 313 connections within the knowledge network and the entire Gene Expression Omnibus database. Clinical and experimental data from the two clinical BioBridge studies of chronic obstructive pulmonary disease (COPD) has been integrated with these public resources. This information is combined with BioBridge literature-mining derived molecular networks for COPD, cardiac disease, chronic systemic inflammation, diabetes and lung and muscle specific signalling subnetworks. Experimental molecular sets encompass gene expression, metabolomics and proteomics data. Exercise and COPD specific kinetic and metabolic data relevant to constrain muscle metabolic models has been extracted from 30 published clinical trials.
Finally the mathematical models and probabilistic networks generated within the BioBridge project are fed back into BioXM. While the wizards in MathModelica do a good job assisting the user in creating SBML exportable compartments, substances, and reactions in Modelica, they do not let the user edit these components once created. We intend to address this limitation in future releases. The current version includes Metabolic Control Analysis (MCA) and dynamic sensitivity analysis; however there are various other common tasks like parameter estimation, model reduction, and stochastic simulation that could be added in the future.
Conclusions
The ambition is to create a bridge between the systems biology community and the Modelica community. The main benefits of the project is that it makes it possible to 1) convert an existing SBML model and benefit from Modelicas multi domain technology when extending the model, and 2) get direct access to biological databases and tools when developing a biochemical pathway in Modelica.
A public available Modelica library, BioChem, for modelling cellular pathways in Modelica has been developed and a toolbox, MathModelica Systems Biology; that allows import/export to SBML, publishing of models and results with connections to biochemical databases has also been developed. The translation from SBML to Modelica allows people that work with SBML, to import their models to MathModelica and use the full strength of the Modelica language to expand their models. All in all, we believe that hierarchical modelling has a strong future for modelling of complex biological processes, and that MathModelica, in communication with SBML-based software and models, has the potential to take a leading role in such efforts.
